Call : (603) 313-2003
Find us on:
About us

MediPatch Technologies and Consulting far exceeds all competitors in the field of transdermal patches and pharmaceutical counseling. We have over 30 years of experience with transdermal patches and 13 years of experience in pharmaceutical consulting. No other company in the San Diego, California area has as much experience as MediPatch Technologies and Consulting. We work with many large pharmaceutical companies all over the United States. Our list of clients includes Mylan Inc. and Syntropharma Ltd.


Take a look at our services pages to see what exactly we offer and what we can do for your company. We can help you take the next step and make a medical difference in the world. Contact us today to get started.

Business provided:
  • Feasibility study of transdermal delivery of biologically active ingredients from different matrices.
  • Manufacturing small batches of “private label” monolithic patches, reservoir patches and “pad’ patches.
  • Custom analytical services for determining transdermal doses of active ingredients from creams and gels using In Vitro Franz Cell method.
  • Manufacturing custom silicone gels for scars healing.
  • Manufacturing custom hydrogels for application in EKG electrodes and for topical application of active ingredients into the skin.
  • Manufacturing of small batches of custom adhesive laminates for further converting and printing labels.

Ludwig J. Weimann, PhD

MediPatch 4863 Mount Hay Dr
San Diego CA, 92117
Telephone: 858-568-2462
Email :lweima.patch@together.net
Web Url :www.medipatchtechnologies.com
EDUCATION:
  • PhD. in Physical Chemistry
    Poznan University, Poznan, Poland, Sept.1970
  • MS in Physical Chemistry
    Poznan University, Poznan, Poland, May 1963
  • POSTDOCTORAL TRAINING
  • NIH Postdoctoral Fellow
    University of Missouri-Kansas City,
    Kansas City, Missouri 1972-1973
  • Postdoctoral Exchange Scholar
    Kansas University, Lawrence, Kansas 1970 – 1971

Ludwig J. Weimann, PhD

  • Set up a new transdermal manufacturing facilities for a start up pharmaceutical company in San Diego Innovative Pharmaceuticals LLC, San Diego 2007-2009
  • Contributed to a design of the manufacturing facilities and manufacturing equipment for a foreign pharmaceutical company 2010
  • Developed eight transdermal systems for three domestic and two foreign pharmaceutical companies 1998-2010
  • Developed ten transdermal patch formulations – two FDA approved generic transdermal systems: Nitroglycerine patch and Estrogen patch, both presently marketed by Mylan Pharmaceuticals, Inc., and one NDA submitted 1984 – 1998
  • Developed topical patch formulation containing Vitamins C, E, and A, And a hydrogel patch for topical pain relieve
  • Developed adhesive hydrogels for EKG
  • Studied feasibility of transdermal delivery of protein drugs enhanced by ultrasound (patented) 1998-2002
  • Directed research on more than 200 custom projects in area of topical and wound dressing devices at Bertek Inc from 1980 to 1992
  • Familiar with c-GMP rules and regulatory aspects of transdermal patch manufacturing
  • Familiar with industrial coating and lamination
  • Developed radiation curable systems:
    Clear coatings, silicone release coatings and EKG hydrogel
  • Directed the Transdermal Drug Delivery R&D staff of one Ph.D. chemist, six BS chemist, three technicians and one administrative secretary at Mylan Technologies Inc from 1992 to 1998
APPOINTMENTS
  • Sole Proprietor and Consultant
    Medipatch Technologies and Consulting
    San Diego, CA 92124 April 2008 – present
  • Consultant
    Medipatch Technologies, Inc, (Founder)
    San Diego, CA 92124 May 2006 – March 2008
  • Consultant
    Medipatch Technologies LLC, (Founder)
    Burlington, VT 05401 April 2004 – 2006
  • Consultant
    Lumar, Ltd., (Founder)
    Burlington, VT 05401, July 1998 – Dec.2004
  • R&D Partner
    Ultra-Sonic Technologies, LLC (Co-founder) 2002 – 2004
    Saint Albans, VT 05401
  • Research Associate Professor
    Biophysics Research,
    Physics Dept., University of Vermont
    Burlington, VT 05404 Sept.1998 – Dec 2002
  • IP Associate
    IpCapital Group
    Williston, VT 05495 April 2000-August 2001
  • Senior Research Director
    Transdermal Preformulation Department
    Bertek, Inc., – Pharmaceutical Division
    110 Lake St, St Albans, VT 05477 Jan. 1994 – May 1998
  • R&D Director
    Bertek, Inc.,
    110 Lake St, St Albans, VT 05477 Aug. 1980 – 1994
  • Head of Transdermal Research Group
    Bertek, Inc., -Pharmaceutical Division
    110 Lake St, St Albans, VT 05477 1989 – 1994
  • Consultant in radiation curable inks and coatings 1980
  • R&D Director
    KC Coatings, Inc., Kansas City, Kansas 1976 – 1980
  • Teaching Instructor
    Donnelly College, Kansas City, Kansas, 1979 – 1980
  • Visiting Assistant Professor
    University of Missouri-Kansas City,
    Kansas City, Missouri 1975 – 1976
  • Teaching Instructor
    University of Missouri – Kansas City,
    Kansas City, Missouri 1973 – 1975
  • Teaching Instructor
    Poznan University, Poznan, Poland 1963 – 1970
PROFESSIONAL SOCIETIES:
  • AAPS 1993 – present
    Controlled Release Society 1992 – present
    American Chemical Society 1974 – present
    Polish Chemical Society 1964 – 1971
PEER REVIEWED PUBLICATIONS
  • Z.P. Zagorski and L.J. Weimann
    “On the formation of Hydrogen Peroxide in Gamma Irradiated Frozen Alkaline Solutions of High Concentration”.
    Report #549/XVII – Institute of Nuclear Research Warsaw, Poland, July 1964.
  • J. Wojtczak and L.J. Weimann
    “Photosensitivity of Carbon Suboxide in Hexane”.
    Roczniki Chemii (Ann. Soc. Chim. Polonorum) 40, 1953, 1966.
  • J. Wojtczak, and L.J. Weimann
    “Einige Bemerkungen zur Struktur des Kohlensuboxidopolymeren”.
    Monatshefte fur Chemie, 99,501,1968.
  • J. Wojtczak, L.J. Weimann, A Dezor & A. Wieckowski
    “ESR Study on Irradiated Frozen Carbon Suboxide”.
    Roczniki Chemii (Ann, Soc. Chim. Polonorum) 43, 2103 1969.
  • L.J. Weimann
    “Role of the Excited States of Carbon Suboxide in Organic Photosynthesis”
    Ph.D. Thesis.
    Poznan University, Poznan, Poland 1970.
  • L.J. Weimann and R.E. Christoffersen
    “Ab Initio” Calculations on Large Molecules Using Molecular Fragments. Cumulenes and Related Molecules”.
    J. Am. Chem. Soc., 95, 2074, 1973.
  • G.M. Maggiora and L.J. Weimann
    “Electronic Structure of Porphyrins. All Valence-Electron Self-Consistent Field Calculations of the Spectra of Dianion and Free Base Porphins”.
    Chem. Phys. Letters, 22, 297, 1973.
  • G.M. Maggiora and L.J. Weimann
    “Electronic Structure of Porphyrins III. All Valence Electron SCF MO CI Calculations of the Excited States of Dianion and Free Base Reduced Porphyrins”.
    Int. J. Quantum Chem., Quantum Biology Symposium #1, 179, 1974.
  • L.J. Weimann, G.M. Maggiora & P.E. Blatz
    “Excited States of All-Trans and 11-cis Retinals. All Valence Electron SCF MO CI Calculations”.
    Int. J. Quantum Chem., Quantum Biology Symposium, #2, 9, 1975.
  • M. Muthukumar & L.J. Weimann
    “On the Origin of the Bathochromic Shift in Rhodopsin”.
    Chem. Phys. Letters, 53, 436, 1978.
  • S. Palamand, A.M. Reed and L.J. Weimann
    “Testing Intelligent Wound Dressing”.
    Journal of Biomaterials Application, 6, 187, 1992.
  • J. Wu, J. Chappelow, J. Yang, and L.Weimann
    “Defects Generated in Human Stratum Corneum Specimens by Ultrasound”
    Ultrasound in Med. & Biol., 24, 1-6, 1998
  • L. Weimann, and J. Wu,
    “Transdermal Delivery of Poly-l-lysine by Sonomacroporation”
    Ultrasound in Med.& Biol., 28, 1173-1180, 2002
  • Ludwig J. Weimann
    “ Semiempirical Determination of Diffusion Coefficient of Drug in Epidermis”
    Poster on XVII Conference of the Polish Pharmaceutical Society, Krakow, Poland , Sept. 11, 1998
  • Ludwig J. Weimann, and Junru Wu,
    “ Enhancement of skin penetration of poly-l-lysine by ultrasound “
    Poster on 26th International Symposium on Controlled Release of Bioactive Materials,
    Boston, July 20-25, 1999
CONFERENCE AND SEMINAR PRESENTATIONS
  • Ludwig J. Weimann
    “UV Chemistry and Controls”.
    Duo-Tech Conference Sponsored by Screen Printing Association Denver, Colorado, August 26-28,1979.
  • Ludwig J. Weimann
    “Transdermal Drug Delivery Systems”.
    Seminar on Medical Adhesives – Technology and Application by Technomic Publishing Co., Inc.,
    Boston, April 10-12, 1996.
  • Ludwig J. Weimann
    “Transdermal Drug Delivery Systems”
    Seminar on Medical Adhesives – Technology and Application by Technomic Publishing Co., Inc.,
    Boston – April 16-18, 1997.
  • Ludwig J. Weimann
    “Transdermal Drug Delivery Systems”
    Seminar on Medical Adhesives – Technology and Application by Technomic Publishing Co., Inc.,
    Minneapolis – May 13-15, 1998
  • Ludwig J. Weimann
    “ Practical Aspects of Formulation and Production of the Transdermal Systems”
    Communicate on XVII Conference of the Polish Pharmaceutical Society,
    Krakow, Poland , Sept. 11, 1998
  • Ludwig J. Weimann
    “ Practical and Theoretical Aspects of Formulation of the Transdermal Systems “
    Lecture at the University of Medical Sciences, Department of Pharmacy and Medical Analysis, Poznan, Poland, Sept. 15, 1998
  • Ludwig J. Weimann
    “ Transdermal Drug Delivery Systems “.
    Seminar on Medical Adhesives – Technology and Application by Technomic Publishing Co., Inc., Boston, April1 2-14, 1999.
PATENTS
  • “Foam Laminate Transdermal Patch.” US 5,503,844, Apr. 2, 1996.
  • “Foam Laminate Transdermal Patch” US 5,629,014, May 13, 1997.
  • “Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent” US 5,662,926, September 2, 1997.
  • “Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent” US 5,676,969, October 14, 1997.
  • “Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent” US 5,679,373, October 21, 1997.
  • “Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent” US 6,010,715, January 4, 2000
  • “Foam Laminate Transdermal Patch”, EP 0655900, March, 15, 2000
  • “Method And Apparatus For In-Vivo Transdermal And/Or Intradermal Delivery Of Drugs By Sonoporation” US 6,487,447 November, 26, 2002
  • “Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs”, US 20020150613-A1, October 17, 2002
  • “Method and apparatus for Intradermal Incorporation of Microparticles Containing Encapsulated Drugs Using Low Frequency Ultrasound”, US 6,712, 805 B2, March 30, 2004
  • “Transdermal Delivery Using Encapsulated Agent Activated By Ultrasound And/Or Heat” WO/2004/060447 July, 22,2004
  • “Method And Apparatus For In-Vivo Transdermal And/Or Intradermal Delivery Of Drugs By Sonoporation” US 6,842,641 January 11, 2005
  • “Multi-compartment transdermal pain control device” 20070248657 A1 October 25, 2007
  • “Intradermal Incorporation Of Microparticles Containing Encapsulated Drugs Using Low Frequency Ultrasound” US 7,232,431, June 19, 2007
  • “Pharmaceutical Composition For Treatment Of Addiction”, WO 2009/106831 A2 September 3, 2009
  • “Twin Transdermal Drug Delivery Patch” US 2010/0222751 A2 Patent Application, 2010
  • “Transdermal Reservoir Patch” 20100221313 A1 September 2, 2010
BOOKS
  • “Performance of the UV-Curable Inks”, Chapter #3 of the book entitled, “UV Curing in Screen Printing for Printed Circuits and Graphic Arts”, published by Technology Marketing Corp., 1980.
Connect with us
10601- G Tierrasanta
San Diego, CA 92124
(858) 568-2462
www.medipatchtechnologies.com
Find us on the map
Contact us
Name:
Phone:
Email: